| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cyclerion Therapeutics, Inc. | Director | Common Stock | 20,000 | $67,900 | $3.40 | 30 Nov 2023 | Direct |
| Voyager Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 24,000 | 03 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VYGR | Voyager Therapeutics, Inc. | 03 Jun 2025 | 1 | $0 | 4 | Director | 04 Jun 2025, 21:02 |
| VYGR | Voyager Therapeutics, Inc. | 05 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 16:17 |
| CYCN | Cyclerion Therapeutics, Inc. | 30 Nov 2023 | 1 | $0 | 4 | Director | 04 Dec 2023, 16:04 |
| VYGR | Voyager Therapeutics, Inc. | 06 Jun 2023 | 1 | $0 | 4 | Director | 07 Jun 2023, 16:34 |
| CYCN | Cyclerion Therapeutics, Inc. | 25 Jul 2022 | 1 | $0 | 4/A | Director | 27 Jul 2022, 16:40 |
| CYCN | Cyclerion Therapeutics, Inc. | 25 Jul 2022 | 0 | $0 | 3 | Director | 26 Jul 2022, 16:30 |
| VYGR | Voyager Therapeutics, Inc. | 06 Jun 2022 | 1 | $0 | 4 | Director | 08 Jun 2022, 16:37 |
| VYGR | Voyager Therapeutics, Inc. | 03 Jun 2021 | 1 | $0 | 4 | Director | 04 Jun 2021, 16:33 |